Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest ...

German pharmaceutical company Boehringer Ingelheim has entered a multi-year collaboration with Tempus AI (Nasdaq: TEM), ...

Boehringer will gain access to the de-identified database of Tempus, which comprises clinical, imaging and molecular data.

The $163 million includes a Headquarters Building Quasi-Endowment Fund. ADA sold its headquarters at 211 E. Chicago Ave. to ...

GeneDx is expanding product lines, improving margins, and increasing insurance coverage, with the recent acquisition. Read ...

We recently published a list of 10 Firms Crushing the Market. In this article, we are going to take a look at where Tempus AI ...

On Tuesday, the Labor Department reported that the Consumer Price Index for April rose by only 0.2 percent last month, ...

We’re winding down earnings season, and the old Wall Street adage that “earnings drive stock prices” continues to prove true.

Despite a turbulent 2025, Ark Invest CEO Cathie Wood is currently sitting on a big win with her investment in Tempus AI ...

The post shared by Ark’s multiomics analyst, Nemo M Despot, underscored that “AI is powering a self-reinforcing loop that ...

If the current pace of exits persists, it would take 30 years for every U.S. company on The Crunchbase Unicorn Board to go ...